GILEAD SCIENCES, INC.

Holdings History for Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

Symbol: XLO on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 14,517,678 shares
Security Ownership %: 20%

Shares, Excluding Options vs Price

Value, Excluding Options

GILEAD SCIENCES, INC. ownership in Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

12 Feb 2026 - GILEAD SCIENCES, INC. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 14,517,678 shares of Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO). This represents 20% ownership of the company. In their previous filing dated 14 Aug 2025, GILEAD SCIENCES, INC. had reported owning 10,613,944 shares, indicating an increase of +37%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
GILEAD SCIENCES, INC.	20%	0%	$9,581,667	14,517,678	+3,903,734	+37%	$0.66	13G/A	31 Dec 2025	12 Feb 2026, 16:39
GILEAD SCIENCES, INC.	20%	0%	$7,748,179	10,613,944	+1,508,493	+17%	$0.73	13G/A	30 Jun 2025	14 Aug 2025, 16:42
GILEAD SCIENCES INC	20%		$6,920,143	9,105,451			$0.76	13G/A	18 Dec 2024	19 Dec 2024, 16:15

Holdings date	Weight	Change	Value $	Shares	Price	All Holders
31 Dec 2025	0.3%	0%	$5,829,310	9,105,451	$0.64	Q4 2025
30 Sep 2025	0.43%	0%	$7,673,164	9,105,451	$0.84	Q3 2025
30 Jun 2025	0.48%	0%	$6,190,796	9,105,451	$0.68	Q2 2025
31 Mar 2025	0.56%	0%	$6,595,989	9,105,451	$0.72	Q1 2025
31 Dec 2024	0.56%	0%	$8,695,706	9,105,451	$0.96	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.